Solicitation of Nominations for Appointment to the Mine Safety and Health Research Advisory Committee (MSHRAC), 11977-11978 [2019-06089]
Download as PDF
Federal Register / Vol. 84, No. 61 / Friday, March 29, 2019 / Notices
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: Day 1
meeting agenda includes welcome
remarks and a Center update by NCHS
leadership; update on the release of
linked data files; update on the
Implementation of the Redesigned
National Health Interview Survey;
report by the National Health Interview
Survey Redesign Key Health Indicators
Workgroup; update on Patient Centered
Outcomes Research Trust Fund Projects;
Day 2 meeting agenda includes update
on Comparability Study for OPIOID
Questions; an update on NCHS
Statistics Maternal Mortality Data.
Agenda items are subject to change as
priorities dictate.
Chief Operating Officer, Centers for
Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06087 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
jbell on DSK30RV082PROD with NOTICES
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, is limited only by room seating
SUMMARY:
VerDate Sep<11>2014
17:48 Mar 28, 2019
Jkt 247001
available, (120). The public is also
welcome to listen to the meeting via
teleconference at 888–455–9748,
passcode: 4373458; 100 teleconference
lines are available. Time will be
available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt of
written public comment is May 2, 2019.
All requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length and delivered in 3 minutes or
less. Members of the public who wish
to provide public comments should
plan to attend the public comment
session at the start time listed. Please
note that the public comment period
may end before the time indicated,
following the last call for comments.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
Registration is required to attend in
person or on the phone. Interested
parties must be processed in accordance
with established federal policies and
procedures and may register at https://
www.cdc.gov/hicpac/.
DATES: The meeting will be held on May
16, 2019, 9:00 a.m. to 5:00 p.m., EDT,
and May 17, 2019, 9:00 a.m. to 12:00
p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia
30329–4027 and teleconference at 888–
455–9748, passcode: 4373458.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027 Telephone (404)
498–0730. Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
11977
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup and the Neonatal Intensive
Care Unit (NICU) Guideline Workgroup.
The agenda also includes updates on
CDC and DHQP activities. Agenda items
are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06088 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Mine Safety and
Health Research Advisory Committee
(MSHRAC)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
MSHRAC, NIOSH. The MSHRAC
consists of 13 experts in fields
associated with mining safety and
health. Nominations are being sought
for individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
mining safety and health, such as
mining engineering, industrial hygiene,
occupational safety and health
engineering, chemistry, safety and
health education, ergonomics,
epidemiology, statistics, and
psychology. Federal employees will not
be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
MSHRAC’s objectives.
SUMMARY:
E:\FR\FM\29MRN1.SGM
29MRN1
11978
Federal Register / Vol. 84, No. 61 / Friday, March 29, 2019 / Notices
Nominations for membership on
the MSHRAC must be received no later
than May 10, 2019. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Jeffrey H. Welsh, Designated
Federal Officer, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention, 626
Cochrans Mill Road, Pittsburgh, PA
15236. Telephone: (412) 386–4040.
FOR FURTHER INFORMATION CONTACT:
Pauline Benjamin, Program Specialist,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road, MS E–20, Atlanta, GA 30329–
4027. Telephone: (404) 498–1376, fte5@
cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for NIOSH MSHRAC membership each
year, and provides a slate of nominees
for consideration to the Secretary of
HHS for final selection. HHS notifies
selected candidates of their
appointment near the start of the term
in January 2020, or as soon as the HHS
selection process is completed. Note
that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year. SGE
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D Cover letter, including a description
of the candidate qualifications and why
jbell on DSK30RV082PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:48 Mar 28, 2019
Jkt 247001
the candidate would be a good fit for
MSHRAC.
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06089 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Office of Infectious Diseases (BSC, OID).
This meeting is open to the public,
limited only by the space available; the
meeting room will accommodate up to
100 people. The public is also welcome
to listen to the meeting by telephone,
limited only by the number of ports
available (100); the toll-free dial-in
number is 1–877–951–7311, with a
passcode of 2286986.
DATES: The meeting will be held on May
7, 2019, 12:30 p.m. to 5:30 p.m., EDT,
and May 8, 2019, 8:30 a.m. to 3:30 p.m.,
EDT.
ADDRESSES: CDC, Global
Communications Center, 1600 Clifton
Road NE, Building 19, Auditorium B3,
Atlanta, Georgia 30329–4027; also 1–
877–951–7311, with a passcode of
2286986.
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 9990
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, MPH, Designated Federal
Officer, CDC, 1600 Clifton Road NE,
Mailstop H24–12, Atlanta, Georgia
30329–4027, Telephone (404) 639–4840;
SWiley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director and the Deputy
Director for Infectious Diseases (DDID),
CDC; and the Directors of the National
Center for Emerging and Zoonotic
Infectious Diseases, the National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention, and the National Center
for Immunization and Respiratory
Diseases, CDC, in the following areas:
Strategies, goals, and priorities for
programs; research within the national
centers; and overall strategic direction
and focus of DDID and the national
centers.
Matters To Be Considered: The agenda
will include updates from the infectious
disease national centers and the Center
for Global Health along with focused
discussions on recent outbreaks and
affected populations and the CDC
Surveillance Strategy and Public Health
Data Strategy. Reports back from three
workgroups will also be given: (1) The
Board’s Acute Flaccid Myelitis (AFM)
Task Force; (2) the Board’s Food Safety
Modernization Act Surveillance
Working Group; and (3) the Vectorborne Diseases Workgroup of the BSC,
OID, and the Board of Scientific
Counselors, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06086 Filed 3–28–19; 8:45 am]
BILLING CODE 4163–19–P
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 84, Number 61 (Friday, March 29, 2019)]
[Notices]
[Pages 11977-11978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Mine Safety
and Health Research Advisory Committee (MSHRAC)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the MSHRAC, NIOSH. The MSHRAC
consists of 13 experts in fields associated with mining safety and
health. Nominations are being sought for individuals who have expertise
and qualifications necessary to contribute to the accomplishments of
the committee's objectives. Nominees will be selected based on
expertise in the fields of mining safety and health, such as mining
engineering, industrial hygiene, occupational safety and health
engineering, chemistry, safety and health education, ergonomics,
epidemiology, statistics, and psychology. Federal employees will not be
considered for membership. Members may be invited to serve for up to
four-year terms. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of MSHRAC's
objectives.
[[Page 11978]]
DATES: Nominations for membership on the MSHRAC must be received no
later than May 10, 2019. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Jeffrey H. Welsh,
Designated Federal Officer, National Institute for Occupational Safety
and Health, Centers for Disease Control and Prevention, 626 Cochrans
Mill Road, Pittsburgh, PA 15236. Telephone: (412) 386-4040.
FOR FURTHER INFORMATION CONTACT: Pauline Benjamin, Program Specialist,
National Institute for Occupational Safety and Health, Centers for
Disease Control and Prevention, 1600 Clifton Road, MS E-20, Atlanta, GA
30329-4027. Telephone: (404) 498-1376, [email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees (SGEs),
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
NIOSH MSHRAC membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
January 2020, or as soon as the HHS selection process is completed.
Note that the need for different expertise varies from year to year and
a candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. Government. Candidates should submit
the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] Cover letter, including a description of the candidate
qualifications and why the candidate would be a good fit for MSHRAC.
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both CDC and the Agency for Toxic Substances
and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06089 Filed 3-28-19; 8:45 am]
BILLING CODE 4163-18-P